Cargando…

Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer

Neoadjuvant chemotherapy with docetaxel, oxaliplatin, fluorouracil, and leucovorin (FLOT regimen) has shown promising results in terms of pathological response and survival rate in patients with locally advanced resectable gastric cancer (LAGC). However, tegafur gimeracil oteracil potassium capsule...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sah, Birendra Kumar, Zhang, Benyan, Zhang, Huan, Li, Jian, Yuan, Fei, Ma, Tao, Shi, Min, Xu, Wei, Zhu, Zhenglun, Liu, Wentao, Yan, Chao, Li, Chen, Liu, Bingya, Yan, Min, Zhu, Zhenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705676/ https://www.ncbi.nlm.nih.gov/pubmed/33257672 http://dx.doi.org/10.1038/s41467-020-19965-6

Ejemplares similares

Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
por: Sah, Birendra Kumar, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
por: Xu, Wei, et al.
Publicado: (2021)

CT-Based Radiomics Showing Generalization to Predict Tumor Regression Grade for Advanced Gastric Cancer Treated With Neoadjuvant Chemotherapy
por: Chen, Yong, et al.
Publicado: (2022)

FLOT Neoadjuvant Chemotherapy Followed by Laparoscopic D2 Gastrectomy in the Treatment of Locally Resectable Advanced Gastric Cancer
por: Zhang, Shun, et al.
Publicado: (2020)

The metastasis suppressor SOX11 is an independent prognostic factor for improved survival in gastric cancer
por: QU, YING, et al.
Publicado: (2014)

Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
por: Shi, Min, et al.
Publicado: (2021)

Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021)

Is adjuvant chemotherapy necessary for early gastric cancer?
por: Mei, Yu, et al.
Publicado: (2022)

Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy
por: Paszt, Attila, et al.
Publicado: (2023)

Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020)

Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
por: Li, Hao, et al.
Publicado: (2014)

Gastric cancer surgery: Billroth I or Billroth II for distal gastrectomy?
por: Sah, Birendra K, et al.
Publicado: (2009)

Nomograms Involving HER2 for Predicting Lymph Node Metastasis in Early Gastric Cancer
por: Mei, Yu, et al.
Publicado: (2021)

Characterization of Differentially Expressed Genes Involved in Pathways Associated with Gastric Cancer
por: Li, Hao, et al.
Publicado: (2015)

MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells
por: Zhao, Yu, et al.
Publicado: (2014)

DKK1 as a robust predictor for adjuvant platinum chemotherapy benefit in resectable pStage II-III gastric cancer
por: Fan, Zhiyuan, et al.
Publicado: (2022)

Adjuvant Chemotherapy in pT2N0M0 Gastric Cancer: Findings From a Retrospective Study
por: Mei, Yu, et al.
Publicado: (2022)

Osteopontin Splice Variants Differentially Exert Clinicopathological Features and Biological Functions in Gastric Cancer
por: Tang, Xiaojian, et al.
Publicado: (2012)

ABO Blood Group System and Gastric Cancer: A Case-Control Study and Meta-Analysis
por: Wang, Zhiwei, et al.
Publicado: (2012)

CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway
por: Zang, Mingde, et al.
Publicado: (2014)

Downregulation of CDH11 Promotes Metastasis and Resistance to Paclitaxel in Gastric Cancer Cells
por: Yang, Zhongyin, et al.
Publicado: (2021)

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO
por: Götze, Thorsten O., et al.
Publicado: (2021)

Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients
por: Zang, Mingde, et al.
Publicado: (2017)

CD36 mediates palmitate acid-induced metastasis of gastric cancer via AKT/GSK-3β/β-catenin pathway
por: Pan, Jiaomeng, et al.
Publicado: (2019)

Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway
por: Du, Tao, et al.
Publicado: (2014)

Preoperative Chemotherapy for Gastric Cancer: Personal Interventions and Precision Medicine
por: Xu, Wei, et al.
Publicado: (2016)

Prognostic role of iodine values for gastric cancer after neoadjuvant chemotherapy: a strong independent prognostic factor
por: Zhang, Yang, et al.
Publicado: (2022)

MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer
por: Yu, Beiqin, et al.
Publicado: (2016)

Hypermethylated FAM5C and MYLK in Serum as Diagnosis and Pre-Warning Markers for Gastric Cancer
por: Chen, Lu, et al.
Publicado: (2012)

Prognostic Role of MicroRNA-21 in Gastric Cancer: A Meta-Analysis
por: Wang, Zhenqiang, et al.
Publicado: (2014)

Se maintenir à flot
por: Auer, Rebecca Ann C.
Publicado: (2021)

Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
por: Villanueva, Luis, et al.
Publicado: (2021)

REG4 promotes peritoneal metastasis of gastric cancer through GPR37
por: Wang, Hexiao, et al.
Publicado: (2016)

Dynamics and Endocytosis of Flot1 in Arabidopsis Require CPI1 Function
por: Cao, Yangyang, et al.
Publicado: (2020)

Decrease of miR-202-3p Expression, a Novel Tumor Suppressor, in Gastric Cancer
por: Zhao, Yu, et al.
Publicado: (2013)

ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis
por: Ma, Xingjie, et al.
Publicado: (2016)

The validity of neoadjuvant chemotherapy with paclitaxel plus S-1 is not inferior to that of SOX regimen for locally advanced gastric cancer: an observational study
por: Zhang, Chenghai, et al.
Publicado: (2022)

MTA2 promotes gastric cancer cells invasion and is transcriptionally regulated by Sp1
por: Zhou, Chenfei, et al.
Publicado: (2013)

LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation
por: Wang, Zhenqiang, et al.
Publicado: (2021)

HOXB9 induction of mesenchymal-to-epithelial transition in gastric carcinoma is negatively regulated by its hexapeptide motif
por: Chang, Qing, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pjvfrrgf4lo05ubt50hojhi9oi